PubMed Health⌕ Search

PubMed · 3073005

Laser angioplasty.

Abstract

Laser technology clearly offers new approaches to the treatment of cardiovascular disease. The ability to transmit intense laser energy through optical fibers may allow precise ablation of pathologic cardiovascular tissues. This potential has stimulated extensive research on laser vaporization of atherosclerotic plaque, or laser angioplasty. Despite the preceding several years of research, there is currently no widespread laser angioplasty system in clinical use. The goal of complete atherosclerotic plaque vaporization without damage to the underlying arterial wall still remains elusive. This article reviews multiple different approaches to the development of laser angioplasty systems. It is too early to predict if all (or any) of these systems will be perfected to the degree necessary to provide cardiologists with a safe and effective laser angioplasty system. It is also difficult to predict the effect that the technologically simpler mechanical recanalization devices and arterial stents will have on laser angioplasty development. Nevertheless, laser angioplasty remains an exciting and promising approach for intravascular recanalization by vaporization of atherosclerotic plaque.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L I Deckelbaum. 1988. Laser angioplasty.. https://pubmed.ncbi.nlm.nih.gov/3073005/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years.

AIMS: Moderate-to-severe chronic renal failure is an established risk factor for cardiovascular disease and mortality. However, most studies have been performed in selected populations and the impact of very small decrements of renal function on long-term cardiac morbidity and mortality has not yet been established. Also, the cut-off level of glomerular filtration rate (GFR) from which cardiovascular risk increases has not exactly been established. This study wants to address these questions. METHODS AND RESULTS: Ten year follow-up of a representative population-based cohort comprised 8913 randomly selected, apparently healthy participants. Participants were randomly drawn from Belgian voting lists. Cardiovascular risk factors were noted. Serum creatinine values were corrected to isotope dilution mass spectrometry standard, and GFR was calculated using the recently modified 'modification of diet in renal disease' equation. Participants were followed for 10 years, and cause-specific death was registered by analysis of death certificates. The probability to die from all causes or from cardiovascular causes during the 10 year follow-up period increased in each quartile of GFR, even after correction for different other comorbid conditions. CONCLUSION: Even mild renal failure is an independent risk factor for cardiovascular mortality within 10 years in an apparently healthy unselected population. This detrimental effect starts already at a relatively high GFR of 90 mL/min/1.73 m2 and remains present after correction for other established cardiovascular risk factors.

Cardiovascular Diseases↗

Quality physical intervention activity for persons with Down syndrome.

Persons with Down syndrome (DS) are at risk for a life of inactivity that can result in a multitude of medical problems including heart and vascular diseases. This review presents findings regarding the physical status of individuals with DS, as well as proper interventions found to improve the physical fitness and general health for this population. This review was written with the intent to suggest practical directions in planning and implementing quality physical intervention programs for this population.

Cardiovascular Diseases↗